SS&C Technologies (SSNC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Q1 2026 delivered strong results despite macro headwinds, with adjusted revenue up 8.8% and adjusted organic revenue growth at 5.0%.
Adjusted consolidated EBITDA reached $651M, up 10%, and adjusted diluted EPS rose 14.2% to $1.69.
Raised full-year 2026 guidance based on robust performance and visibility.
Continued focus on AI-driven innovation, with new product launches such as Blue Prism WorkHQ and platform enhancements.
$233.3M returned to shareholders through share repurchases and dividends in Q1 2026.
Financial highlights
Q1 2026 adjusted revenue: $1.648B, up 8.8% year-over-year; adjusted operating income: $633.6M, up 10.1%.
Adjusted consolidated EBITDA: $651M, margin of 39.5%.
Adjusted diluted EPS: $1.69, up 14.2%; adjusted net income: $417.7M.
GAAP net income: $226.1M, up 6.2%.
Cash from operating activities: $299.7M, up 10.1% year-over-year.
Outlook and guidance
Q2 2026 adjusted revenue guidance: $1.64B–$1.68B, with 5.6% organic growth at midpoint; adjusted diluted EPS: $1.64–$1.70.
Full-year 2026 adjusted revenue guidance: $6.664B–$6.824B, with 5.3% organic growth at midpoint; adjusted diluted EPS: $6.74–$7.06.
FY 2026 cash from operating activities expected between $1.713B–$1.813B.
Capital expenditures expected at 4.4%–4.8% of revenue; effective tax rate guidance: 21.5%–23.5%.
Latest events from SS&C Technologies
- AI-driven growth, high margins, and disciplined acquisitions fuel strong financial outlook.SSNC
47th Annual Raymond James Institutional Investor Conference21 Apr 2026 - Disciplined growth, automation, and high retention drive strong margins and future opportunities.SSNC
UBS Financial Services Conference 202612 Apr 2026 - Record performance, robust governance, and expanded equity plan headline this year's proxy.SSNC
Proxy filing8 Apr 2026 - Virtual annual meeting to vote on directors, pay, auditor, and stock plan; board recommends approval.SSNC
Proxy filing8 Apr 2026 - Record revenue, double-digit EPS growth, and robust 2026 outlook with strong cash flow.SSNC
Q4 20255 Feb 2026 - Q2 2024 saw 6.5% revenue growth, 45.6% higher net income, and a $1B buyback program.SSNC
Q2 20242 Feb 2026 - Restructured verticals, margin gains from Blue Prism, and healthcare growth via DomaniRx partnership.SSNC
2024 RBC Capital Markets Financial Technology Conference1 Feb 2026 - Strong recurring revenue and margin growth expected, driven by technology and efficiency gains.SSNC
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - 4–8% organic growth outlook driven by platform integration, AI, and cross-sell initiatives.SSNC
Analyst Day 202420 Jan 2026